COVID-19 and gynecological cancer: a review of the published guidelines.

Published on Jun 23, 2020in International Journal of Gynecological Cancer2.095
· DOI :10.1136/IJGC-2020-001634
Christina Uwins4
Estimated H-index: 4
,
Geetu Bhandoria2
Estimated H-index: 2
+ 6 AuthorsAgnieszka Michael24
Estimated H-index: 24
(University of Surrey)
Sources
Abstract
On March 11, 2020 the COVID-19 outbreak was declared a 'pandemic' by the World Health Organization COVID-19 is associated with higher surgical morbidity and mortality An array of guidelines on the management of cancer during this pandemic have been published since the first reports of the outbreak This narrative review brings all the relevant information from the guidelines together into one document, to support patient care We present a detailed review of published guidelines, statements, comments from peer-reviewed journals, and nationally/internationally recognized professional bodies and societies' web pages (in English or with English translation available) between December 1, 2019 and May 27, 2020 Search terms included combinations of COVID, SARS-COV-2, guideline, gynecology, oncology, gynecological, cancer Recommendations for surgical and oncological prioritization of gynecological cancers are discussed and summarized The role of minimally invasive surgery, patient perspectives, medico-legal aspects, and clinical trials during the pandemic are also discussed The consensus is that elective benign surgery should cease and cancer surgery, chemotherapy, and radiotherapy should continue based on prioritization Patient and staff face-to-face interactions should be limited, and health resources used efficiently using prioritization strategies This review and the guidelines on which it is based support the difficult decisions currently facing us in gynecological cancer It is a balancing act: limited resources and a hostile environment pitted against the time-sensitive nature of cancer treatment We can only hope to do our best for our patients with the resources available to us
📖 Papers frequently viewed together
3 Citations
12 Citations
30 Citations
References30
Newest
Background The COVID-19 pandemic has disrupted routine hospital services globally. This study estimated the total number of adult elective operations that would be cancelled worldwide during the 12 weeks of peak disruption due to COVID-19. Methods A global expert response study was conducted to elicit projections for the proportion of elective surgery that would be cancelled or postponed during the 12 weeks of peak disruption. A Bayesian β-regression model was used to estimate 12-week cancellati...
429 CitationsSource
#1F. Di MarzoH-Index: 2
#2Massimo SartelliH-Index: 53
Last. Maurizio CardiH-Index: 13
view all 9 authors...
68 CitationsSource
#1Andrea Ciavattini (Marche Polytechnic University)H-Index: 24
#2Giovanni Delli Carpini (Marche Polytechnic University)H-Index: 14
Last. Murat GultekinH-Index: 20
view all 12 authors...
The COVID-19 pandemic caused by SARS-CoV-2 has radically changed global healthcare. On May 13, 2020, all countries of the European Region reported their COVID-19 status, with 1 757 814 confirmed cases and 157 923 confirmed deaths.[1][1] Each country has initiated measures to reduce the impact
14 CitationsSource
#1Yoav Mintz (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 1
#2Alberto ArezzoH-Index: 46
Last. Abe FingerhutH-Index: 71
view all 7 authors...
7 CitationsSource
#2Aneel Bhangu (UoB: University of Bristol)H-Index: 37
Last. Deborah S KellerH-Index: 1
view all 1 authors...
Summary Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection con...
624 CitationsSource
#1Bhavana Pothuri (NYU: New York University)H-Index: 25
#2Angeles Alvarez Secord (Duke University)H-Index: 59
Last. R. Wendel NaumannH-Index: 11
view all 11 authors...
Abstract Objectives The COVID-19 pandemic has consumed considerable resources and has impacted the delivery of cancer care. Patients with cancer may have factors which place them at high risk for COVID 19 morbidity or mortality. Highly immunosuppressive chemotherapy regimens and possible exposure to COVID-19 during treatment may put patients at additional risk. The Society of Gynecologic Oncology convened an expert panel to address recommendations for best practices during this crisis to minimiz...
30 CitationsSource
#1Yoav MintzH-Index: 30
#2Alberto Arezzo (UNITO: University of Turin)H-Index: 46
Last. Abe Fingerhut (SJTU: Shanghai Jiao Tong University)H-Index: 71
view all 6 authors...
47 CitationsSource
#1Andrea Ciavattini (Marche Polytechnic University)H-Index: 24
#2Giovanni Delli Carpini (Marche Polytechnic University)H-Index: 14
Last. M. BarberoH-Index: 10
view all 9 authors...
In the context of the COVID-19 pandemic, patients need to be evaluated within 2-4 weeks in the following cases: cytology result of ""squamous cell carcinoma,"" ""atypical glandular cells, favor neoplastic,"" ""endocervical adenocarcinoma in situ,"" or ""adenocarcinoma""; histopathological diagnosis of suspected invasion from cervical/vaginal biopsy, or invasive disease after a cervical excision procedure, vaginal excision, or vulvar biopsy/excision; sudden onset of strongly suggestive symptoms f...
13 CitationsSource
INTRODUCTION: The outbreak of coronavirus disease 2019 (COVID-19) has spread to many countries and has been declared a global health emergency. Our center is located in the south of Italy where the infection rates were low and the clusters of COVID-19 positive patients were small and inhomogeneous. The aim of this short report is to share our experience as a starting point for the management of the steady state of the pandemic. METHODS: The safety of the patients and department staff required a ...
6 CitationsSource
#1Eva Segelov (Monash University)H-Index: 24
#2C. Underhill (UNSW: University of New South Wales)H-Index: 13
Last. C. Raina MacIntyre (UNSW: University of New South Wales)H-Index: 51
view all 17 authors...
Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions ...
27 CitationsSource
Cited By12
Newest
#1Faiza GabaH-Index: 6
#1Faiza Gaba (Aberd.: University of Aberdeen)
Last. İlker SelçukH-Index: 9
view all 16 authors...
Introduction null The SARS-CoV-2 global pandemic has caused a crisis disrupting health systems worldwide. While efforts are being made to determine the extent of the disruption, the impact on gynecological oncology trainees/training has not been explored. We conducted an international survey of the impact of SARS-CoV-2 on clinical practice, medical education, and mental well-being of surgical gynecological oncology trainees. null Methods null In our cross-sectional study, a customized web-based ...
Source
#1Zahra Siavashpour (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 6
Last. Mosayyeb Mobasheri (TMU: Tarbiat Modares University)
view all 3 authors...
Treatment management of cancer patients in the radiation oncology departments during the current COVID-19 pandemic is challenging. A systematic review of published consensus/guidelines on the role of radiotherapy prioritization, suggested treatment protocols, and set up management was undertaken based on the PRISMA protocol and through PubMed/PMC, Scopus, Google Scholar, Web of Science databases until 01/20/2021. One hundred and sixty-eight publications or regional consensus were included. Summa...
Source
#7Sian Cousins (NIHR: National Institute for Health Research)H-Index: 12
Objectives null COVID-19 presents a risk of infection and transmission for operating theatre teams. Guidelines to protect patients and staff emerged and changed rapidly based on expert opinion and limited evidence. This paper presents the experiences and innovations developed by international surgical teams during the early stages of the pandemic to attempt to mitigate risk. null Design null In-depth, semistructured interviews were audio recorded, transcribed and analysed thematically using meth...
Source
#1Gemma Mancebo (Autonomous University of Barcelona)H-Index: 10
#2Josep-Maria Solé-Sedeño (Autonomous University of Barcelona)H-Index: 3
Last. Ester Miralpeix (Autonomous University of Barcelona)H-Index: 6
view all 8 authors...
The SARS-CoV-2 (COVID-19) pandemic has significantly impacted the management of patients with gynecologic cancers. Many centers have reduced access to routine visits to avoid crowded waiting areas and specially to reduce the infection risk for oncologic patients. The goal of this review is to propose a surveillance algorithm for patients with gynecologic cancers during the COVID-19 pandemic based on existing evidence and established guidelines. It is time to consider strategies based on telemedi...
2 CitationsSource
#1Abhishek Shinghal (HBNI: Homi Bhabha National Institute)
#2Sonz Paul (HBNI: Homi Bhabha National Institute)
Last. Jai Prakash Agarwal (HBNI: Homi Bhabha National Institute)H-Index: 6
view all 16 authors...
PURPOSE To report real world compliance to radiation in gynecological cancers during the complete lockdown phase of COVID 19 pandemic. METHODS From 23rd March, 2020 until 30th June, 2020 complete lockdown was imposed in India. During this period there was restructuring of cancer care and radiation oncology department due to operational policies prevalent in the institution, and the care for gynaecological cancer was based on the evolving international recommendations. Institutional review board ...
Source
BACKGROUND During the COVID-19 pandemic, cancer care had to be reorganized; national and international recommendations were published to manage anticancer treatments safely and to reduce the risk of SARS-CoV-2 infection for patients and health workers. OBJECTIVE To evaluate whether the adoption of recommendations for the management of patients with gynaecologic cancer receiving treatment during the pandemic resulted in containment of infections and continuing oncologic care. METHODS Based on the...
Source
#1Guillaume BlacheH-Index: 2
#2Houssein El HajjH-Index: 2
Last. Eric LambaudieH-Index: 28
view all 11 authors...
We describe and analyze a "care as usual" strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January 21 and May 12, 2020. We compared the surgical activity and surgical and oncologic outcomes during the pre-lockdown period and the pandemic period. The main objective was to evaluate the impact of the...
Source
INTRODUCTION AND HYPOTHESIS: The coronavirus (COVID-19) pandemic has impacted health systems worldwide. There is a continuing need for clinicians to adapt practice to facilitate timely provision of medical care, whilst minimising horizontal transmission. Guidance and recommendations are increasingly available, and this rapid review aimed to provide a timely evidence synthesis on the current recommendations surrounding urogynaecological care. METHODS: We performed a literature review using PubMed...
1 CitationsSource
#1Sohan Lal Solanki (HBNI: Homi Bhabha National Institute)H-Index: 8
#2Mrida A. K. Jhingan (HBNI: Homi Bhabha National Institute)H-Index: 1
Last. Avanish Saklani (HBNI: Homi Bhabha National Institute)H-Index: 17
view all 3 authors...
Source
#2Kaival K. Gundavda (ACTREC: Tata Memorial Hospital)
In the wake of the COVID-19 pandemic, due to reasons beyond control, health care workers have struggled to deliver treatment for the patients with cancer. The concern for otherwise healthy patients with curable cancers that require timely intervention or therapy is the risk of contracting COVID-19 may outweigh the benefits of cancer treatment. Lack of international guidelines leaves health care providers with a case-to-case approach for delivering optimal cancer care in the wake of the pandemic....
3 CitationsSource